June 2020 PMID 32345485

Treatment for emerging viruses: Convalescent plasma and COVID-19.

Bethany L Brown, Jeffrey McCullough

Full text PDF Download social card

Mentions

Peak: 4 in May 2020

across 5 sources since May 2020

Extended reach

88,236

potential audience

Total likes

Video views

483

Mentions per month

May 2020 – Aug 2020

Where it's discussed

News10 articles
X / Twitter5 posts
Blogs3 articles
Facebook2 posts
YouTube1 videos

AI synopsis

What people are saying

The discussions demonstrate a balanced curiosity about the potential of convalescent plasma, with comments referencing promising initial trials and recent developments, such as the first randomized trial results, which underscores a moderate level of engagement and interest. The tone varies from cautious optimism to neutral, reflecting the preliminary nature of the findings and the ongoing evaluation of treatments during the pandemic.

AgreementNeither agree nor disagree

The discussions reflect a cautious acknowledgment of the potential of convalescent plasma, with some support for its promise, but not full endorsement of its effectiveness.

InterestModerate interest

Participants show moderate curiosity about the topic, highlighted by mentions of promising trial results and ongoing developments, but without deep dives into specifics.

EngagementModerate engagement

The interactions involve referencing recent trials and ongoing research, indicating some level of engagement, though mostly surface-level mentions rather than detailed analysis.

ImpactNeutral impact

The discussions suggest limited immediate impact, primarily highlighting developments and potential rather than widespread policy or treatment changes.

Abstract in brief

Convalescent plasma therapy is a potential treatment for COVID-19, especially when vaccines or specific therapies are unavailable, due to the urgent need to manage the pandemic.
The report emphasizes the importance of quickly establishing protocols for collecting, preparing, and administering convalescent plasma, along with considering pathogen reduction treatments to enhance safety.
Rapid development and implementation of convalescent plasma programs are crucial for providing immediate treatment options, and further research is needed to improve therapies and understand the disease better.

Read the full abstract

All mentions

Russian COVID-19 Vaccine Development and Convalescent Plasma Therapy

The video discusses Russia's advancements in COVID-19 vaccination, including approval and vaccination plans, as well as recent findings on convalescent plasma's potential benefits in severe COVID-19 cases, emphasizing…

Dr. Deepak Natarajan · Aug 7, 2020 483 views

Dr(Prof)Deepak Natarajan MBBS MD DM

@deepakdeepak · X

Aug 7, 2020 · 1 like · 6,264 followers View post →

No one

@ungubunugu1274 · X

RT @FluTrackers: Transfus Apher Sci. Treatment for emerging viruses: Convalescent plasma and COVID-19 https://t.co/oC0nbdQwFe h/t tetano #c…

May 2, 2020 · 4 shares · 3,518 followers View post →

Tigress

@TigressEllie · X

RT @FluTrackers: Transfus Apher Sci. Treatment for emerging viruses: Convalescent plasma and COVID-19 https://t.co/oC0nbdQwFe h/t tetano #c…

May 1, 2020 · 4 shares · 8,175 followers View post →

Mehabe

@mehabecapital · X

TRANSFUS APHER SCI. TREATMENT FOR EMERGING VIRUSES: CONVALESCENT PLASMA AND COVID-19

May 1, 2020 · 2,545 followers View post →

FluTrackers.com

@FluTrackers · X

Transfus Apher Sci. Treatment for emerging viruses: Convalescent plasma and COVID-19 https://t.co/oC0nbdQwFe h/t tetano #coronavirus

May 1, 2020 · 3 likes · 4 shares · 67,227 followers View post →